NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000220

Registered date:20/09/2005

Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedacute myelocytic leukemia
Date of first enrollment2000/04/01
Target sample size288
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)set therapy individualised therapy

Outcome(s)

Primary Outcomecomplete remission rate, survival period
Secondary Outcomeover all survival rate, event-free survival

Key inclusion & exclusion criteria

Age minimum65years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaHistory of acute myocardial infarction within 1 year History of renal insuficiancy Poorly controlled diabetes Poorly controleed angina Uncontrolled active infection Liver cirrohsis Severe psychiatric disease Positive for HIV antibody Positive for HCV antibody Positive for HBs antigen

Related Information

Contact

public contact
Name Atsushi Wakita, MD
Address 1-2-23 Wakamizu, Chikusa-ku, Nagoya, JAPAN Japan
Telephone 052-721-7171
E-mail wakita@higashi-hosp.jp
Affiliation Higashi Municipal Hospital of Nagoya Hematology and Oncology
scientific contact
Name Atsushi Wakita, MD
Address 1-2-23 Wakamizu, Chikusa-ku, Nagoya, JAPAN Japan
Telephone 052-721-7171
E-mail
Affiliation Higashi Municipal Hospital of Nagoya Hematology and Oncology